Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Elanco Animal Health ( (ELAN) ) has shared an announcement.
On October 31, 2025, Elanco Animal Health Incorporated announced an amendment to its Credit Agreement, initially dated August 1, 2020. This amendment involves refinancing a portion of its outstanding term loans by securing new U.S. dollar and euro-denominated term loans, as well as farm credit term loans, with maturity dates extending to 2032 and 2029. The proceeds from these refinancing facilities, along with cash on hand, were used to refinance existing borrowings and cover related fees and expenses, potentially impacting the company’s financial structure and operational flexibility.
The most recent analyst rating on (ELAN) stock is a Buy with a $23.00 price target. To see the full list of analyst forecasts on Elanco Animal Health stock, see the ELAN Stock Forecast page.
Spark’s Take on ELAN Stock
According to Spark, TipRanks’ AI Analyst, ELAN is a Outperform.
Elanco Animal Health’s stock score reflects a strong earnings call performance and positive technical indicators, suggesting bullish momentum. Financial performance shows recovery, though historical volatility and debt levels remain concerns. Valuation is moderate, with no dividend yield, impacting its appeal to income investors.
To see Spark’s full report on ELAN stock, click here.
More about Elanco Animal Health
Elanco Animal Health Incorporated operates in the animal health industry, focusing on providing products and services that enhance the health and well-being of animals. The company is involved in the development and marketing of a wide range of veterinary products for pets and livestock, catering to a global market.
Average Trading Volume: 7,154,920
Technical Sentiment Signal: Buy
Current Market Cap: $11B
See more insights into ELAN stock on TipRanks’ Stock Analysis page.